Celularity (CELUW) Operating Margin (2020 - 2025)
Celularity (CELUW) reported Operating Margin of 486.89% for Q4 2025, up 183573.0% year-over-year from N/an in Q4 2024, and up 299.44% quarter-over-quarter from 244.13% in Q3 2025.
Celularity (CELUW) Operating Margin (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Operating Margin data on file, last reported at 486.89% in Q4 2025.
- Operating Margin for Q4 2025 came in at 486.89%, up 183573.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 72.57% (up 3173.0% YoY), and the FY2025 annual result was 72.57%, down 183.0% from the prior year.
- Operating Margin grew to 486.89% in Q4 2025 per CELUW's latest filing, from 244.13% in the prior quarter.
- Over five years, Operating Margin peaked at 486.89% in Q4 2025 and troughed at 2621.66% in Q3 2023.
- A 5-year average of 569.35% and a median of 190.34% in 2022 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2023 and 2024: Operating Margin tumbled 248512 bps in 2023, then soared 249766 bps in 2024.
- A 5-year view of Operating Margin shows it stood at 307.89% in 2021, then soared by 238 bps to 423.47% in 2022, then slumped by 74 bps to 109.93% in 2023, then slumped by 1327 bps to 1348.84% in 2024, then jumped by 136 bps to 486.89% in 2025.
- Business Quant data shows CELUW's Operating Margin at 486.89% in Q4 2025, 244.13% in Q3 2025, and 276.57% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | 486.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 486.89% |
| Sep 30, 2025 | -244.13% |
| Jun 30, 2025 | -276.57% |
| Mar 31, 2025 | -91.77% |
| Dec 31, 2024 | -1,348.84% |
| Sep 30, 2024 | -124.00% |
| Jun 30, 2024 | -84.01% |
| Mar 31, 2024 | -50.24% |
| Dec 31, 2023 | 109.93% |
| Sep 30, 2023 | -2,621.66% |
| Jun 30, 2023 | -1,445.75% |
| Mar 31, 2023 | -1,623.13% |
| Dec 31, 2022 | 423.47% |
| Sep 30, 2022 | -136.54% |
| Jun 30, 2022 | 110.57% |
| Mar 31, 2022 | -701.16% |
| Dec 31, 2021 | -307.89% |
| Sep 30, 2021 | 102.60% |
| Jun 30, 2021 | -1,895.87% |
| Mar 31, 2021 | -1,668.98% |